Edges in Network
| Network | GSE16987_egf1520 - GSE16987 - SiGN-BN HC+Bootstrap |
| Network Description | A new gene expression signature, the ClinicoMolecular Triad Classification, may improve prediction and prognostication of breast cancer at the time of diagnosis |
| Node | LYPD5 |
| Upstream (Parents) |
|---|
| (<<) ATP11C → LYPD5 |
| (<<) CALB1 → LYPD5 |
| (<<) CCNB2 → LYPD5 |
| (<<) CCNE1 → LYPD5 |
| (<<) CDK6 → LYPD5 |
| (<<) CDKN2A → LYPD5 |
| (<<) CHODL → LYPD5 |
| (<<) CHST3 → LYPD5 |
| (<<) CREB3L4 → LYPD5 |
| (<<) E2F2 → LYPD5 |
| (<<) ELF5 → LYPD5 |
| (<<) FERMT1 → LYPD5 |
| (<<) FZD9 → LYPD5 |
| (<<) GPX7 → LYPD5 |
| (<<) IGFBP2 → LYPD5 |
| (<<) KCNN4 → LYPD5 |
| (<<) LEMD1 → LYPD5 |
| (<<) MLPH → LYPD5 |
| (<<) MYO1E → LYPD5 |
| (<<) NCOA7 → LYPD5 |
| (<<) PHGDH → LYPD5 |
| (<<) PLK1 → LYPD5 |
| (<<) POP1 → LYPD5 |
| (<<) PPP1R12B → LYPD5 |
| (<<) PRKX → LYPD5 |
| (<<) RHOB → LYPD5 |
| (<<) SEMA3A → LYPD5 |
| (<<) SMO → LYPD5 |
| (<<) SPDEF → LYPD5 |
| (<<) TCF7L1 → LYPD5 |
| (<<) TEX10 → LYPD5 |
| (<<) VAV3 → LYPD5 |
| Downstream (Children) |
|---|
| LYPD5 → ADCY6 (>>) |
| LYPD5 → ARSJ (>>) |
| LYPD5 → CISH (>>) |
| LYPD5 → CMTM7 (>>) |
| LYPD5 → CREBBP (>>) |
| LYPD5 → DUSP5 (>>) |
| LYPD5 → FZD4 (>>) |
| LYPD5 → GSTK1 (>>) |
| LYPD5 → IER3 (>>) |
| LYPD5 → IRAK1 (>>) |
| LYPD5 → KLF2 (>>) |
| LYPD5 → MRAS (>>) |
| LYPD5 → NFIA (>>) |
| LYPD5 → PLAUR (>>) |
| LYPD5 → PRKCSH (>>) |
| LYPD5 → RAVER1 (>>) |
| LYPD5 → RPIA (>>) |
| LYPD5 → SFN (>>) |
| LYPD5 → SGMS2 (>>) |
| LYPD5 → SHFM1 (>>) |
| LYPD5 → SOCS2 (>>) |
| LYPD5 → STYK1 (>>) |
| LYPD5 → TFF1 (>>) |
| LYPD5 → TMEM45B (>>) |
